Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090246257> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2090246257 endingPage "241" @default.
- W2090246257 startingPage "238" @default.
- W2090246257 abstract "Abstract: This study clarified changes in the serum amikacin (AMK) levels in the blood of 5 patients (4 men and 1 woman; average age 59.2 ± 5.9 years) with serious acute renal failure treated by continuous arteriovenous hemofiltration (CAVH). The following principal results were obtained. (A) The average remaining rate of AMK in the blood after 6 h was 60.8 ± 5.3% and 50.4 ± 5.3% after 12 h. The average half-life period (t1/2ß) of AMK in the blood during CAVH was 18.3 ± 3.4 h. (B) The remaining rate of AMK in the blood after 12 h correlated significantly with the blood urea nitrogen (BUN) level (r = 0.71, p < 0.05) and with the volume of urine excreted per day (r =-0.71, p < 0.05). (C) The average lowest AMK concentration after 24 h for a continuous 17-day period was 3.3 μ/ml. These results suggest that the administration of 100 mg of AMK once a day is useful and safe for patients with serious acute renal failure treated by CAVH and that it will not accumulate in the body." @default.
- W2090246257 created "2016-06-24" @default.
- W2090246257 creator A5001396238 @default.
- W2090246257 creator A5009634100 @default.
- W2090246257 creator A5012819275 @default.
- W2090246257 creator A5014496223 @default.
- W2090246257 creator A5023359954 @default.
- W2090246257 creator A5027602581 @default.
- W2090246257 creator A5033508919 @default.
- W2090246257 creator A5039607833 @default.
- W2090246257 creator A5044518379 @default.
- W2090246257 creator A5049659161 @default.
- W2090246257 creator A5054233385 @default.
- W2090246257 creator A5061825004 @default.
- W2090246257 creator A5072390804 @default.
- W2090246257 date "1989-06-01" @default.
- W2090246257 modified "2023-09-25" @default.
- W2090246257 title "Changes of the Serum Amikacin (AMK) Level in Patients with Serious Acute Renal Failure Treated by Continuous Arteriovenous Hemofiltration (CAVH)" @default.
- W2090246257 cites W2008056852 @default.
- W2090246257 cites W2035719698 @default.
- W2090246257 cites W2040759300 @default.
- W2090246257 cites W2084137610 @default.
- W2090246257 doi "https://doi.org/10.1111/j.1525-1594.1989.tb02869.x" @default.
- W2090246257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2764763" @default.
- W2090246257 hasPublicationYear "1989" @default.
- W2090246257 type Work @default.
- W2090246257 sameAs 2090246257 @default.
- W2090246257 citedByCount "3" @default.
- W2090246257 countsByYear W20902462572013 @default.
- W2090246257 crossrefType "journal-article" @default.
- W2090246257 hasAuthorship W2090246257A5001396238 @default.
- W2090246257 hasAuthorship W2090246257A5009634100 @default.
- W2090246257 hasAuthorship W2090246257A5012819275 @default.
- W2090246257 hasAuthorship W2090246257A5014496223 @default.
- W2090246257 hasAuthorship W2090246257A5023359954 @default.
- W2090246257 hasAuthorship W2090246257A5027602581 @default.
- W2090246257 hasAuthorship W2090246257A5033508919 @default.
- W2090246257 hasAuthorship W2090246257A5039607833 @default.
- W2090246257 hasAuthorship W2090246257A5044518379 @default.
- W2090246257 hasAuthorship W2090246257A5049659161 @default.
- W2090246257 hasAuthorship W2090246257A5054233385 @default.
- W2090246257 hasAuthorship W2090246257A5061825004 @default.
- W2090246257 hasAuthorship W2090246257A5072390804 @default.
- W2090246257 hasConcept C126322002 @default.
- W2090246257 hasConcept C126894567 @default.
- W2090246257 hasConcept C185592680 @default.
- W2090246257 hasConcept C2777427914 @default.
- W2090246257 hasConcept C2778063415 @default.
- W2090246257 hasConcept C2778176769 @default.
- W2090246257 hasConcept C2778865887 @default.
- W2090246257 hasConcept C2780026642 @default.
- W2090246257 hasConcept C2780091579 @default.
- W2090246257 hasConcept C2780472472 @default.
- W2090246257 hasConcept C42219234 @default.
- W2090246257 hasConcept C501593827 @default.
- W2090246257 hasConcept C55493867 @default.
- W2090246257 hasConcept C71924100 @default.
- W2090246257 hasConceptScore W2090246257C126322002 @default.
- W2090246257 hasConceptScore W2090246257C126894567 @default.
- W2090246257 hasConceptScore W2090246257C185592680 @default.
- W2090246257 hasConceptScore W2090246257C2777427914 @default.
- W2090246257 hasConceptScore W2090246257C2778063415 @default.
- W2090246257 hasConceptScore W2090246257C2778176769 @default.
- W2090246257 hasConceptScore W2090246257C2778865887 @default.
- W2090246257 hasConceptScore W2090246257C2780026642 @default.
- W2090246257 hasConceptScore W2090246257C2780091579 @default.
- W2090246257 hasConceptScore W2090246257C2780472472 @default.
- W2090246257 hasConceptScore W2090246257C42219234 @default.
- W2090246257 hasConceptScore W2090246257C501593827 @default.
- W2090246257 hasConceptScore W2090246257C55493867 @default.
- W2090246257 hasConceptScore W2090246257C71924100 @default.
- W2090246257 hasIssue "3" @default.
- W2090246257 hasLocation W20902462571 @default.
- W2090246257 hasLocation W20902462572 @default.
- W2090246257 hasOpenAccess W2090246257 @default.
- W2090246257 hasPrimaryLocation W20902462571 @default.
- W2090246257 hasRelatedWork W1975751417 @default.
- W2090246257 hasRelatedWork W2350237293 @default.
- W2090246257 hasRelatedWork W2362214344 @default.
- W2090246257 hasRelatedWork W2371369831 @default.
- W2090246257 hasRelatedWork W2377006731 @default.
- W2090246257 hasRelatedWork W2731626834 @default.
- W2090246257 hasRelatedWork W3009333829 @default.
- W2090246257 hasRelatedWork W3031668149 @default.
- W2090246257 hasRelatedWork W3033761619 @default.
- W2090246257 hasRelatedWork W4318694129 @default.
- W2090246257 hasVolume "13" @default.
- W2090246257 isParatext "false" @default.
- W2090246257 isRetracted "false" @default.
- W2090246257 magId "2090246257" @default.
- W2090246257 workType "article" @default.